SEARCH RESULTS for MILLENNIUM PHARMACEUTICALS, INC.

Recent Patent Assignments Patent Assignments - (Total found: 22)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
14-Aug-2017

(X0) 14514687: Aurora Kinase Inhibitors for Inhibiting Mitotic Progression

(A1) 20150166545: Aurora Kinase Inhibitors for Inhibiting Mitotic Progression

CLAIBORNE, CHRISTOPHER F.

SELLS, TODD B.

STROUD, STEPHEN G.

MILLENNIUM PHARMACEUTICALS, INC.

43273/379

24-Jul-2017

(X0) 14966821: HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

(A1) 20160331756: HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

BIOGEN IDEC MA INC.

MILLENNIUM PHARMACEUTICALS, INC.

43064/716

07-Jul-2017

(X0) 14346225: Methods for the Harvesting of Cell Cultures

(A1) 20140324360: Methods for the Harvesting of Cell Cultures

OPPENHEIM, SHELDON F.

CARRIGAN, KEVIN C.

MILLENNIUM PHARMACEUTICALS, INC.

42926/764

30-Jun-2017

(X0) 15304947: QUINOXALINE COMPOUNDS AND USES THEREOF

(A1) 20170174704: QUINOXALINE COMPOUNDS AND USES THEREOF

CARDIN, DAVID P.

HU, YONGBO

LEE, HONG MYUNG

SHI, ZHAN

VYSKOCIL, STEPAN

MILLENNIUM PHARMACEUTICALS, INC.

42869/269

30-Jun-2017

(X0) 15304947: QUINOXALINE COMPOUNDS AND USES THEREOF

(A1) 20170174704: QUINOXALINE COMPOUNDS AND USES THEREOF

TAKEDA PHARMACEUTICAL COMPANY LIMITED

MILLENNIUM PHARMACEUTICALS, INC.

42869/300

12-Jun-2017

(X0) 14741530: NOVEL MOLECULES OF THE CARD-RELATED PROTEIN FAMILY AND USES THEREOF

(A1) 20160122730: NOVEL MOLECULES OF THE CARD-RELATED PROTEIN FAMILY AND USES THEREOF

BERTIN, JOHN

MILLENNIUM PHARMACEUTICALS, INC.

42656/960

12-Jun-2017

(X0) 14872477: METHODS AND KITS FOR MONITORING THE EFFECTS OF IMMUNOMODULATORS ON ADAPTIVE IMMUNITY

(A1) 20160251716: METHODS AND KITS FOR MONITORING THE EFFECTS OF IMMUNOMODULATORS ON ADAPTIVE IMMUNITY

FEDYK, ERIC R.

MILLENNIUM PHARMACEUTICALS, INC.

42658/735

12-Jun-2017

(X0) 15170328: E1 ENZYME MUTANTS AND USES THEREOF

(A1) 20170107579: E1 ENZYME MUTANTS AND USES THEREOF

AMIDON, BENJAMIN STONE

BROWNELL, JAMES E.

GAVIN, JAMES M.

KOENIG, ERIK M.

SINTCHAK, MICHAEL D.

SMITH, PETER G.

MILLENNIUM PHARMACEUTICALS, INC.

42669/867

24-May-2017

(X0) 15170328: E1 ENZYME MUTANTS AND USES THEREOF

(A1) 20170107579: E1 ENZYME MUTANTS AND USES THEREOF

AMIDON, BENJAMIN STONE

BROWNELL, JAMES E.

GAVIN, JAMES M.

KOENIG, ERIK M.

SINTCHAK, MICHAEL D.

SMITH, PETER G.

MILLENNIUM PHARMACEUTICALS, INC.

42479/791

03-May-2017

(X0) 14643773: CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF

(A1) 20160031908: CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF

LULY, JAY R

HARRIMAN, GERALDINE CB

CARSON, KENNETH G

GHOSH, SHOMIR

ELDER, AMY M

MATTIA, KAREN M

MILLENNIUM PHARMACEUTICALS, INC.

42199/229

01-Mar-2017

(X0) 15215012: FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

(A1) 20160340432: FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

FOX, IRVING H.

SCHOLZ, CATHERINE

MILLENNIUM PHARMACEUTICALS, INC.

41398/933

24-Feb-2017

(X0) 14328256: METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

(A1) 20150018351: METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

BIOGEN IDEC MA INC.

MILLENNIUM PHARMACEUTICALS, INC.

41347/885

15-Feb-2017

(X0) 15305340: ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY

(A1) 20170037151: ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY

BRAKE, RACHAEL L.

BURKHARDT, ANNE L.

HE MCDOUGALL, HELEN D.

KANNAN, KARUPPIAH

THEISEN, MATTHEW

TIRRELL, STEPHEN M.

MILLENNIUM PHARMACEUTICALS, INC.

41245/752

01-Jul-2016

(X0) 11500378: METHOD OF ACYLATING MAYTANSINOL WITH CHIRAL AMINO ACIDS

(A1) 20070037972: METHOD OF ACYLATING MAYTANSINOL WITH CHIRAL AMINO ACIDS

(B2) 7598375: METHOD OF ACYLATING MAYTANSINOL WITH CHIRAL AMINO ACIDS

CARROZZELLA, DARREN J.

HO, GUOJIE

N/A

MILLENNIUM PHARMACEUTICALS, INC.

39052/966

15-Apr-2016

(X0) 14788675: HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

(A1) 20160009744: HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

DUFFY, MATTHEW O.

ENGLAND, DYLAN B.

FREEZE, BRIAN SCOTT

HU, ZHIGEN

LANGSTON, STEVEN P.

MCINTYRE, CHARLES J.

MIZUTANI, HIROTAKE

XU, HE

MILLENNIUM PHARMACEUTICALS, INC.

38284/140

15-Apr-2016

(X0) 14788675: HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

(A1) 20160009744: HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

TAKEDA PHARMACEUTICAL COMPANY LIMITED

MILLENNIUM PHARMACEUTICALS, INC.

38285/434

06-Apr-2016

(X0) 14054970: SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

(A1) 20140275093: SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

BLACKBURN, CHRISTOPHER

GIGSTAD, KENNETH M.

HARRISON, SEAN J.

XU, HE

MILLENNIUM PHARMACEUTICALS, INC.

38189/471

18-Mar-2016

(X0) 14373985: METHOD OF TREATMENT OF NASOPHARYNGEAL CANCER

(A1) 20140357596: METHOD OF TREATMENT OF NASOPHARYNGEAL CANCER

BLAKEMORE, STEPHEN J.

DI BACCO, ALESSANDRA M.

MULLIGAN, GEORGE J.

MILLENNIUM PHARMACEUTICALS, INC.

38007/857

18-Mar-2016

(X0) 14373991: METHODS OF TREATMENT OF CANCER

(A1) 20160008382: METHODS OF TREATMENT OF CANCER

BLAKEMORE, STEPHEN J.

DI BACCO, ALESSANDRA M.

MULLIGAN, GEORGE J.

MILLENNIUM PHARMACEUTICALS, INC.

38007/888

18-Mar-2016

(X0) 14356968: BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS

(A1) 20150184246: BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS

BERGER, ALLISON

BERNARD, HUGUES

CHATTOPADHYAY, NIBEDITA

KOENIG, ERIK M.

MULLIGAN, GEORGE J.

SCHU, MATTHEW C.

MILLENNIUM PHARMACEUTICALS, INC.

38008/201

08-Feb-2016

(X0) 13949346: Proteasome Inhibitors And Methods Of Using The Same

(A1) 20140088042: Proteasome Inhibitors And Methods Of Using The Same

(B2) 9233115: Proteasome Inhibitors And Methods Of Using The Same

TEVA PHARMACEUTICALS

N/A

MILLENNIUM PHARMACEUTICALS, INC.

37671/460

05-Feb-2016

(X0) 14792762: SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

(A1) 20160031820: SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

BLACKBURN, CHRISTOPHER

CIAVARRI, JEFFREY P.

GIGSTAD, KENNETH M.

XU, HE

MILLENNIUM PHARMACEUTICALS, INC.

37664/933